ReShape Lifesciences Inc. (RSLS) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Stay updated on ReShape Lifesciences Inc. (RSLS) stock with short-term forecast for year 2025 and long-term price prediction for 2025 - 2050. Access historical performance, see analyst ratings, and follow the latest ReShape Lifesciences Inc. news and developments.
1 Month Prediction
$10.63 [681.54%]
3 Month Prediction
$7.66 [463.57%]
6 Month Prediction
$1.00 [-26.47%]
1 Year Prediction
$1.00 [-26.47%]
3 Year Prediction
$1.00 [-26.47%]
5 Year Prediction
$1.00 [-26.47%]
About ReShape Lifesciences Inc.
ReShape Lifesciences Inc. develops and sells medical devices for weight loss and metabolic disease treatment. It provides solutions for patients with obesity.
The company offers Lap-Band®, an FDA-approved, minimally invasive device that helps patients lose weight by reducing stomach capacity. It also develops the ReShape Vest™ System, an investigational device that mimics stomach volume reduction without altering anatomy.
ReShapeCare™ is a virtual coaching program that provides personalized weight management support. It connects patients with experts who help them track progress and build healthy habits.
The company was founded in 2002 and is headquartered in Irvine, California.
ReShape Lifesciences Inc. (RSLS) Historical Performance
IPO Date
ReShape Lifesciences Inc. (NASDAQ:RSLS) went public on 15 November, 2007.
Change
Since inception, RSLS has decreased by 100.00%. In the last 5 years, RSLS has fallen from $2088.00 to $1.36, a massive -99.93% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $14500.00 and a low of $1.36.
52 Week Range
$1.01
$29.0
The current price $1.36 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
RSLS Stock Price History
Based on RSLS stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the RSLS stock has fallen from $1960.4 - $5037.3 to $1.36 - $3.77, which is down -99.98%. Currently, the stock follows downward trend.
Here, we have calculated stock range of RSLS, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $1960.4 - $5037.3 | $2960.66 | -80.95 | 1 Year Change |
| 2021 | $4756.0 - $14500.0 | $9202.67 | -40.78 | 2 Year Change |
| 2022 | $390.92 - $3683.0 | $1879.88 | -87.9 | 3 Year Change |
| 2023 | $13.22 - $419.92 | $113.98 | -99.27 | 4 Year Change |
| 2024 | $4.46 - $14.79 | $9.2 | -99.94 | 5 Year Change |
| 2025 | $1.36 - $3.77 | $2.56 | -99.98 | 6 Year Change |
RSLS Price Performance
6-Month Performance
RSLS stock dropped by 75.93% in the last six months.
1-Year Performance
The stock has trended downwards by 87.26% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 99.96%.
5-Year Performance
In the last 5 years, the stock has gone down by 99.93%.
According to ReShape Lifesciences Inc.'s historical data, below graph gives us the exact picture of how the RSLS stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 1 year and a decline in 4 years.
2020
21.05% ↓
2021
9.33% ↑
2022
91.78% ↓
2023
96.29% ↓
2024
69.24% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
ReShape Lifesciences Inc. (RSLS) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $2.29 M (Q3)
Revenue for Q3 ending 30th September, 2024 increased 16.64% compared to Q2 ending 30th June, 2024.
Annual Revenue: $8.18 M (1Y)
Revenue for trailing 12 months decreased 5.70% year over year from 31st December, 2023.
If compared to the last 5 years, the revenue has gone down from $11.30 million to $8.18 million, a 27.58% change.
Market Capitalization
ReShape Lifesciences Inc. has a market capitalization of $4.49M, which places RSLS in the nano-cap category.
Fundamental Analysis
EPS: $-3.11 (Q3), $-110.78 (1Y)
EPS decreased 10.63% since last quarter, and decreased 98.25% since last year.
Net Income: $-1.58 M (Q3), $-11.39 M (1Y)
Net Income decreased 0.88% since last quarter, and decreased 75.36% since last year.
Free Cash Flow: $-311.00 T (Q3), $-17.00 M (1Y)
Free Cash Flow decreased 77.08% since last quarter, and decreased 22.83% since last year.
Net Profit Margin: -68.98% (Q3), -139.15% (1Y)
Net Profit Margin decreased 15.02% since last quarter, and decreased 73.87% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for RSLS stock. These indicators help you understand ReShape Lifesciences Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for RSLS stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $3.23 |
| SMA50 | $4.09 |
| SMA200 | $7.86 |
| RSI | 11.73 |
| Beta | 1.44 |
SMA20 > Current Price
This signals RSLS stock is in short-term bearish momentum.
SMA50 > Current Price
This signals RSLS stock is in mid-term bearish momentum.
SMA200 > Current Price
This signals RSLS stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for RSLS stock is Bearish. Out of all indicators, 3 indicates bullish signals, 5 signals bearish trends and 1 gives neutral trends. The RSLS stock forecast was last updated on 21 February, 2025.
ReShape Lifesciences Inc. (RSLS) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to fall to $1.00 by the end of 2025, and can reach around $2.01 to $1.33 in 2026. And, the long-term forecast suggests that the stock may further drop to $1.36 - $1.34 in 2028, and $1.09 - $0.98 by 2031. So, the RSLS stock shows a strong downward trend in the next several years.
Short-term RSLS Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-03 | $10.63 | 681.62% |
| 2025-04 | $6.14 | 351.47% |
| 2025-05 | $7.67 | 463.97% |
| 2025-06 | $1.00 | -26.47% |
| 2025-07 | $1.00 | -26.47% |
| 2025-08 | $1.00 | -26.47% |
| 2025-09 | $1.00 | -26.47% |
| 2025-10 | $1.00 | -26.47% |
| 2025-11 | $1.00 | -26.47% |
| 2025-12 | $1.00 | -26.47% |
In 2025, the RSLS stock price is expected to fluctuate between $1.0 and $10.63. According to the monthly forecast, the stock could drop to $1.00 by December 2024. If compared to the RSLS's current price, the stock could lose -26.47% by the end of this year.
Long-term RSLS Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $2.01 | $1.35 | $1.33 | -2.21% |
| 2027 | $1.10 | $1.12 | $0.90 | -33.82% |
| 2028 | $1.36 | $1.13 | $1.34 | -1.47% |
| 2029 | $0.96 | $1.32 | $1.11 | -18.38% |
| 2030 | $0.93 | $0.62 | $1.27 | -6.62% |
| 2031 | $1.09 | $1.19 | $0.98 | -27.94% |
| 2032 | $1.10 | $1.24 | $0.61 | -55.15% |
| 2033 | $1.28 | $1.04 | $0.81 | -40.44% |
| 2034 | $0.91 | $0.69 | $0.88 | -35.29% |
| 2035 | $0.95 | $1.01 | $1.16 | -14.71% |
| 2036 | $1.09 | $0.36 | $1.16 | -14.71% |
| 2037 | $1.34 | $1.10 | $1.22 | -10.29% |
| 2038 | $1.59 | $1.00 | $0.85 | -37.5% |
| 2039 | $0.89 | $0.89 | $1.10 | -19.12% |
| 2040 | $1.18 | $1.06 | $0.62 | -54.41% |
| 2041 | $1.21 | $1.21 | $1.63 | 19.85% |
| 2042 | $1.36 | $0.80 | $0.83 | -38.97% |
| 2043 | $0.63 | $1.28 | $0.38 | -72.06% |
| 2044 | $0.88 | $1.00 | $0.85 | -37.5% |
| 2045 | $1.07 | $1.05 | $1.15 | -15.44% |
| 2046 | $0.84 | $1.09 | $0.49 | -63.97% |
| 2047 | $1.37 | $0.87 | $0.71 | -47.79% |
| 2048 | $0.95 | $1.20 | $1.02 | -25.0% |
| 2049 | $0.76 | $0.92 | $1.29 | -5.15% |
| 2050 | $1.25 | $0.79 | $1.04 | -23.53% |
| 2051 | $1.28 | $1.36 | $1.21 | -11.03% |
ReShape Lifesciences Inc. (RSLS) Stock Price Prediction & Forecast 2025
At the start of 2025, the RSLS stock was at $3.77. Today, it is trading at $1.36, which is -63.93% decrease from price at the beginning of the year. By the end of this year, you can expect the stock to fall to $1.00 by December 2025 with a -26.47% change.
ReShape Lifesciences Inc. (RSLS) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the RSLS stock. During this period, the RSLS's price is forecasted to shift from $2.01 to $1.27, which is -36.82% loss.
In 2026, the stock would possibly open at $2.01, descends to $1.35 by mid-year, and wraps up at $1.33, reflecting a decrease from today's price. Further moving to 2030, the stock can kick off the year at $0.93, drop to $0.62 by mid-year, and finish at $1.27, which is -6.77% change from current price.
ReShape Lifesciences Inc. (RSLS) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $1.09 to $0.62, which is down -27.84%
In 2031, we can expect RSLS to fluctuate between $0.98 and $1.09, a shift indicating a -27.84% loss by year-end compared to current price. And Until 2040, RSLS can likely vary from $0.62 to $1.18. By the end of 2040, the stock could record a -54.49% fall from today's stock price.
ReShape Lifesciences Inc. (RSLS) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the RSLS stock can see an a downturn from $1.21 to $1.04 in this period. In 2041, the stock can experience a low of $1.21 by mid-year, closing the year at $1.63. This results in a -10.68% decrease from today.
Moving towards the end of 2050, RSLS is projected to open the year at $1.25. The stock may dip to $0.79 during mid-year and finish the year at $1.04. Compared to the stock's current price, this translates to an overall loss of -23.81% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
RSLS Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| DXCM | DexCom, Inc. | - | $89.07 | 2.58% ▲ | $116.95 ▲ |
| TIVC | Tivic Health Systems, Inc. | - | $0.69 | 194.32% ▲ | $43.97 ▲ |
| QSI | Quantum-Si incorporated | - | $2.24 | -17.04% ▼ | $35.85 ▲ |
| BMRA | Biomerica, Inc. | - | $0.64 | 113.33% ▲ | $56.25 ▲ |
| INBS | Intelligent Bio Solutions Inc. | - | $2.49 | 41.48% ▲ | -59.84 ▼ |
Last updated Feb 21 at 3:43 AM
RSLS : Buy, Sell Or Hold?
Analyst Ratings
No analyst ratings available for this stock.
Expert Analysis
According to RSLS short-term and long-term forecast, ReShape Lifesciences Inc. shares are projected to go down by 23.53%, and reach a value of $1.04 per share by 2050.
As per technical analysis, indicators show a Bearish sentiment, while Fear & Greed Index stands at 35.714285714285715, which signals Fear. Also, RSLS has recorded 6/30 green days, which reflects a 28.57142857142857% positivity rate with a price volatility of 0.12%.
Plus, Price-to-Earnings (P/E) ratio of 0.017602898 suggests that RSLS stock is overvalued. So, Based on RSLS prediction and analysis, it may be the best time to sell RSLS stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "RSLS” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.